A fresh Cochrane review confirms that SSRIs and SNRIs outperform placebo in treating generalized anxiety disorder (GAD) in adults. 📊 Not only do these medications show superior efficacy, but dropout rates were comparable to placebo—suggesting they’re generally well tolerated.
🔎 The catch? The long-term impact of antidepressants on GAD remains uncertain, highlighting the need for more extended follow-up studies.
💡 Key takeaway: Antidepressants remain a solid treatment option for GAD, but we still have more to learn about their effects over time.
link: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012942.pub2/full
Leave a Reply